Undisclosed MAGE-A1-Specific TCR-T
/ Immupeutics Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
CD8-Targeted Lipid Nanoparticle Delivered Optimized mRNA Enables In Situ Generation of Potent and Safe MAGE-A1-Specific TCR-T Cells
(SITC 2026)
- No abstract available
Lipid Nanoparticle • Oncology • CD8
1 to 1
Of
1
Go to page
1